Hepatitis C OnlineLogo
Section Navigation
Common TitleSIRIUS
Official Title Ledipasvir-sofosbuvir with or without Ribavirin to Treat Patients with HCV Genotype 1 Infection and Crrhosis Non-Responsive to Previous Protease-Inhibitor Therapy: a Randomised, Double-Blind, Phase 2 Trial (SIRIUS)
Phase Phase II
ClinicalTrials.gov NCT01965535
Treatments
Ledipasvir-Sofosbuvir

Ledipasvir-Sofosbuvir

Tradename:HarvoniOther Names:LDV-SOFClass:FDA-Approved
Funding
IndustryGilead Sciences

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.